Loss of MECP2 function, resulting from mutations in 85 to 90 % of individuals affected by RTT [2], is the primary cause of this syndrome, a dominant disorder occurring almost exclusively in females [2, 3]. This evidence concerns the gene MECP2 and Rett syndrome.